Functional Exposed Amino Acids of BauA as Potential Immunogen Against Acinetobacter baumannii F Sefid, I Rasooli, A Jahangiri, H Bazmara Acta biotheoretica 63, 129-149, 2015 | 54 | 2015 |
In Silico Determination and Validation of Baumannii Acinetobactin Utilization A Structure and Ligand Binding Site F Sefid, I Rasooli, A Jahangiri BioMed research international 2013 (1), 172784, 2013 | 53 | 2013 |
Antigenic Properties of Iron Regulated Proteins in Acinetobacter baumannii: An In Silico Approach H Bazmara, I Rasooli, A Jahangiri, F Sefid, SDA Astaneh, Z Payandeh International Journal of Peptide Research and Therapeutics 25, 205-213, 2019 | 32 | 2019 |
SARS-CoV-2 proteome harbors peptides which are able to trigger autoimmunity responses: implications for infection, vaccination, and population coverage M Karami Fath, A Jahangiri, M Ganji, F Sefid, Z Payandeh, ZS Hashemi, ... Frontiers in Immunology 12, 705772, 2021 | 28 | 2021 |
In vivo validation of the immunogenicity of recombinant baumannii acinetobactin utilization a protein (rBauA) H Esmaeilkhani, I Rasooli, S Nazarian, F Sefid Microbial pathogenesis 98, 77-81, 2016 | 26 | 2016 |
Homology Modeling Of A Camelid Antibody Fragment Against A Conserved Region Of Acinetobacter Baumannii Biofilm Associated Protein(Bap) FSIRZ payande Journal of Theoretical Biology 397, 43-51, 2016 | 26 | 2016 |
Immunogenicity of conserved cork and ß-barrel domains of baumannii acinetobactin utilization protein in an animal model YH Sangroodi, I Rasooli, S Nazarian, W Ebrahimizadeh, F Sefid Turkish journal of medical sciences 45 (6), 1396-1402, 2015 | 16 | 2015 |
Immunogenicity of cork and loop domains of recombinant baumannii acinetobactin utilization protein in murine model H Esmaeilkhani, I Rasooli, M Hashemi, S Nazarian, F Sefid Avicenna Journal of Medical Biotechnology 11 (2), 180, 2019 | 14 | 2019 |
Evaluation of OMP A (Outer Membrane Protein A) linear and conformational epitopes in Acinetobacter baumannii P Darbandian, F Sefid International Journal of Advanced Biotechnology and Research (IJBR), 2017 | 13 | 2017 |
Design of a Multi-epitope Vaccine Against Acinetobacter baumannii Using Immunoinformatics Approach M Touhidinia, F Sefid, M Bidakhavidi International Journal of Peptide Research and Therapeutics 27 (4), 2417-2437, 2021 | 12 | 2021 |
In silico homology modeling and epitope prediction of NadA as a potential vaccine candidate in Neisseria meningitidis N Shahsavani, MH Sheikhha, H Yousefi, F Sefid International journal of molecular and cellular medicine 7 (1), 53, 2018 | 12 | 2018 |
Nanobody structure analysis and determination of the functional conserve amino acid with bioinformatic tools Z Payandeh, A Kofeiti, F Sefid France: Natl Agronomique Institute Ltd, 2015 | 12 | 2015 |
In silico engineering towards enhancement of bap–VHH monoclonal antibody binding affinity F Sefid, Z Payandeh, G Azamirad, R Abdolhamidi, I Rasooli International Journal of Peptide Research and Therapeutics 25, 273-287, 2019 | 11 | 2019 |
Evaluation of lamb linear and conformational epitopes on the vibrio Harveyi E Dehghani, F Sefid International Journal of Advanced Biotechnology and Research (IJBR), 2016 | 11 | 2016 |
Identification B and T-Cell epitopes and functional exposed amino acids of S protein as a potential vaccine candidate against SARS-CoV-2/COVID-19 M Tohidinia, F Sefid Microbial Pathogenesis 148, 104459, 2020 | 9 | 2020 |
In Silico Analysis for Determination and Validation of Iron-Regulated Protein from Escherichia coli F Sefid, A Alagheband Bahrami, M Darvish, R Nazarpour, Z Payandeh International Journal of Peptide Research and Therapeutics 25, 1523-1537, 2019 | 9 | 2019 |
Mehdi kalantar, & Fateme Sefid (2016) in silico determination and validation of oprl structure and b cell epitopes as vaccine candidate in pseudomonas aeruginosa A Kofeiti International Journal Of Pharmacy & Technology, 0 | 9 | |
Mehdi kalantar, & Fateme Sefid (2016) in silico potential vaccine against oprf in multidrug-resistant pseudomonas aeruginosa A Kofeiti International Journal Of Pharmacy & Technology, 0 | 9 | |
Assessment of immunogenic linear epitopes on human Immunoglobulin G by immunoinformatic approach F Hajighasemi, S Rohani, F Sefid Res Med 40 (1), 30-35, 2016 | 7 | 2016 |
Atezolizumab and granzyme B as immunotoxin against PD-L1 antigen; an insilico study F Sefid, Z Payandeh, G Azamirad, B Baradaran, M Nabi Afjadi, M Islami, ... In Silico Pharmacology 9, 1-12, 2021 | 6 | 2021 |